Date published: 2025-10-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

LIMP II Activators

Chemicals classified as LIMP II Activators can be understood to operate by modulating cellular pathways that affect lysosomal biogenesis, function, or protein trafficking, thereby indirectly affecting the expression or activity of LIMP II. These chemicals either bind to nuclear receptors like all-trans retinoic acid binding to retinoid receptors or interact with cellular enzymes and signaling molecules, leading to transcriptional changes. For example, forskolin activates adenylate cyclase, thereby increasing cAMP levels, which can influence lysosomal enzyme trafficking.

Moreover, the stress response induced by agents like β-lapachone, which raises reactive oxygen species levels, may activate signaling pathways that upregulate lysosomal components, including LIMP II, to maintain cellular homeostasis. Lipid metabolism modulators such as clofibrate and mevastatin influence peroxisome proliferator-activated receptors and cholesterol biosynthesis pathways, respectively, which could necessitate enhanced lysosomal activity and thus potentially augment the expression of lysosomal proteins such as LIMP II.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

A metabolite of Vitamin A that can regulate gene expression by activating nuclear retinoid receptors, leading to lysosomal biogenesis and possibly enhancing LIMP II expression.

25-Hydroxycholesterol

2140-46-7sc-214091B
sc-214091
sc-214091A
sc-214091C
5 mg
10 mg
25 mg
100 mg
$52.00
$89.00
$166.00
$465.00
8
(2)

A cholesterol derivative that can induce lysosomal biogenesis via liver X receptors (LXR), which may increase the expression of LIMP II as part of the lysosomal response.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

An adenylate cyclase activator that raises intracellular cAMP levels, possibly leading to enhanced lysosomal enzyme trafficking and increased levels of LIMP II in lysosomes.

β-Lapachone

4707-32-8sc-200875
sc-200875A
5 mg
25 mg
$110.00
$450.00
8
(1)

A compound that can increase cellular reactive oxygen species, potentially inducing a compensatory response that includes the upregulation of lysosomal components such as LIMP II.

Clofibrate

637-07-0sc-200721
1 g
$32.00
(1)

A PPARα agonist that can lead to upregulation of lipid metabolism pathways, which may require increased lysosomal activity and potentially higher expression of LIMP II.

Piceatannol

10083-24-6sc-200610
sc-200610A
sc-200610B
1 mg
5 mg
25 mg
$50.00
$70.00
$195.00
11
(2)

An inhibitor of Syk kinase that can modulate signaling pathways associated with cellular stress and potentially enhance lysosomal function and LIMP II levels.

Mevastatin (Compactin)

73573-88-3sc-200853
sc-200853A
10 mg
50 mg
$75.00
$175.00
18
(1)

An HMG-CoA reductase inhibitor that can influence cholesterol biosynthesis and indirectly impact lysosomal function and LIMP II expression.

2-Hydroxypropyl-β-cyclodextrin

128446-35-5sc-203461
sc-203461B
sc-203461C
sc-203461A
1 g
100 g
500 g
5 g
$52.00
$620.00
$1950.00
$130.00
8
(1)

A compound that depletes cholesterol from cell membranes, potentially causing a compensatory increase in lysosomal biogenesis and LIMP II expression.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$96.00
$250.00
$750.00
$1428.00
280
(6)

A V-ATPase inhibitor that raises lysosomal pH, potentially triggering an adaptive response that can include the upregulation of lysosomal proteins like LIMP II.

Adenosine 3′,5′-cyclic monophosphate

60-92-4sc-217584
sc-217584A
sc-217584B
sc-217584C
sc-217584D
sc-217584E
100 mg
250 mg
5 g
10 g
25 g
50 g
$114.00
$175.00
$260.00
$362.00
$617.00
$1127.00
(1)

As a secondary messenger, it can activate PKA and other pathways, potentially leading to changes in gene expression and an increase in lysosomal proteins including LIMP II.